INVIVYD, INC. Increase (Decrease) in Other Noncurrent Liabilities
INVIVYD, INC. (IVVD) reported Increase (Decrease) in Other Noncurrent Liabilities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-03-05
- INVIVYD, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was $0.00.
- INVIVYD, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was $0.00.
- INVIVYD, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-06-30 was $0.00.
- INVIVYD, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-03-31 was $0.00.
- INVIVYD, INC. increase (decrease) in other noncurrent liabilities for fiscal 2025 was $0.00.
- INVIVYD, INC. increase (decrease) in other noncurrent liabilities for fiscal 2024 was -$700.00K, a 200.00% decline from fiscal 2023.
- INVIVYD, INC. increase (decrease) in other noncurrent liabilities for fiscal 2023 was $700.00K.
- INVIVYD, INC. increase (decrease) in other noncurrent liabilities for fiscal 2022 was -$5.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 7 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $0.00 derived: sum of 3 quarters · filed 2026-03-05 | $0.00 10-K · filed 2026-03-05 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-03-05 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-03-05 | $0.00 derived: sum of 4 quarters · filed 2026-03-05 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $0.00 derived: sum of 3 quarters · filed 2026-03-05 | $0.00 derived: sum of 4 quarters · filed 2026-03-05 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $0.00 derived: sum of 3 quarters · filed 2026-03-05 | -$700.00K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | -$700.00K 10-Q · filed 2025-11-06 | -$700.00K derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$700.00K 10-Q · filed 2025-08-14 | -$700.00K derived: sum of 3 quarters · filed 2025-08-14 | $0.00 derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$700.00K 10-Q · filed 2025-05-15 | -$700.00K derived: sum of 2 quarters · filed 2025-05-15 | $0.00 derived: sum of 3 quarters · filed 2025-05-15 | $0.00 derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $700.00K derived: sum of 2 quarters · filed 2025-03-20 | $700.00K derived: sum of 3 quarters · filed 2025-03-20 | $700.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $700.00K derived: sum of 2 quarters · filed 2024-11-14 | $700.00K 10-Q · filed 2024-11-14 | $701.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $1.00K derived: sum of 3 quarters · filed 2024-08-14 | $1.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $1.00K derived: sum of 2 quarters · filed 2024-05-09 | $1.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.00K derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.00K derived: sum of 2 quarters · filed 2024-03-28 | $1.00K derived: sum of 3 quarters · filed 2024-03-28 | -$5.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | -$6.00K 10-Q · filed 2023-11-09 | -$5.00K derived: sum of 4 quarters · filed 2024-02-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$6.00K 10-Q · filed 2023-08-10 | -$5.00K derived: sum of 3 quarters · filed 2024-02-09 | -$5.00K derived: sum of 4 quarters · filed 2024-02-09 | |
| 2022-03-31 | -$6.00K 10-Q · filed 2023-05-11 | -$5.00K derived: sum of 2 quarters · filed 2024-02-09 | -$5.00K derived: sum of 3 quarters · filed 2024-02-09 | -$5.00K derived: sum of 4 quarters · filed 2024-02-09 | |
| 2021-12-31 | $1.00K derived: 8-K 12 month − 10-Q 9 month · filed 2024-02-09 | $1.00K derived: sum of 2 quarters · filed 2024-02-09 | $1.00K derived: sum of 3 quarters · filed 2024-02-09 | $1.00K 8-K · filed 2024-02-09 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-13 | ||||
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |